| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | N/A | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
|
Monday, August 31, 2026 01:30 PM
Company views federal support for Schedule III as a significant evolution in U.S. cannabinoid policy and an important step toward a durable regulatory framework for cannabinoid-based medicines and ...
|
|
Tuesday, August 25, 2026 05:30 AM
File No. 14145, advancing the Company's companion-animal oncology program and marking first milestone under Lupvindol collaborationFORT LAUDERDALE, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- , Inc. (NYSE ...
|
|
Friday, August 21, 2026 05:41 AM
Splash Beverage Group, Inc. (NYSE American: SBEV) (the “Company”) today announced that its corporate name will change to Endovia Health Sciences, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/08/26 | 0.3181 | 0.3181 | 0.263 | 0.302 | 309,452 |
|
|
||||
|
|
||||
|
|